Yes, the PMPRB report you refer to was from 2014. Since then, generic prices have continued to decline. You mentioned a 45% decline. The PMPRB reported that generic prices in Canada had declined more than in any other country.
I think if you take the current data, and include the fair comparison of the lower Canadian dollar than we had in 2014 with the further price reductions, then our prices now are competitive with prices across OECD countries. As I said, we are in ongoing dialogue with the provinces, and now the federal government plans as well, about what the fair price of medicines should be. We believe the prices are now equitable, and we will continue to sit down and negotiate what those prices should be in the future.